Custom Peptide Synthesis
JPT Peptide Technologies has substantial, long-standing expertise in providing custom peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project.
These include state-of-the-art automated synthesis approaches, optimized solution phase procedures, scales ranging from 1mg to several grams, and chemistries involving a variety of protection schemes such as Fmoc and BOC approaches.
Most of JPT's specialty peptides are provided in the highest purity (>95%), with a full range of analyses including LC-MS (trap and/or quad), MALDI-MS, HPLC, AAA, NMR, CE, as well as peptide content determination to confirm the identity and demonstrate the high quality of our peptides.
The exceptional quality and reliability of this service has been appreciated by customers worldwide for many years.
JPT is the premier provider of custom peptides and related services.
Options and Specialties:
- Fluorogenic and chromogenic peptides (AMC, etc.) as well as peptide esters
- Internally quenched peptides (Abz/nitroTyr, EDANS/DABCYL, MCA/DNP) guaranteed without fluorescent impurities
- Immunogenic peptides (MAPs, palmitinylation, Pam3Cys labeling, etc.)
- Phospho-peptides and peptidomimetics (amide bond isosteres, non-natural amino acids, etc.)
- Non-commercial building blocks available
- Labeling (non-radioactive isotope, chromophore, etc.)
- Site-directed conjugations with KLH, BSA, ovalbumine or other carriers
- Cyclic peptides (disulfide bridges, lactams, thioether-bridges, etc.)
- Long peptides (>70 amino acids)
Please inquire about additional services not listed here
Our support service includes:
- Quick and personal consultation with experienced scientists
- Rapid order processing
- Reliable quality control using state-of-the-art techniques
- Fast turnaround times
- Competitive prices
Testimonials:
"The RV 144 HIV trial is considered as one of first successful HIV vaccine trials. It has become clear that the V2 loop of gp120 is an important site for immunogenicity and protection from HIV infection. The use of JPT's PepStar™ microarray technology has been very useful for the correlation of the clincial outcome with humoral immune responses. As have the cyclic peptides been from JPT to validate these findings!"
J. Currier, PhD, Walter Reed Army Institute, Rockville, Maryland, USA
"Our research relies heavily on developing robust high-throughput screens with fluorescent peptides. We have found that JPT’s are the best on the market because the signal-to-noise ratio is very high, providing the sensitivity we need for the screens. Their peptides always perform well. In addition, the knowledge, wonderful customer support, and fast turnaround time provided by JPT have been invaluable in helping us develop the best peptides for our assays."
Prof. Carla Koehler, UCLA, Los Angeles, CA
More testimonials under JPT Testimonials
Selected References:
Self-Reactive Human CD4 T Cell Clones Form Unusual Immunological Synapses
Schubert et al., J. Exp. Med.(2012)
The NK Cell Response to Mouse Cytomegalovirus Infection Affects the Level and Kinetics of the Early CD8+ T-Cell Response
Mitrovic et al., J. Virol. (2012)
The Serum- and Glucocorticoid-inducible Kinase 1 (SGK1) Influences Platelet Calcium Signaling and Function by Regulation of Orai1 Expression in Megakaryocytes
Borst el al., Blood (2012)
Tim50’s Presequence Receptor Domain Is Essential for Signal Driven Transport Across The TIM23 Complex
Schulz et al., J. Cell Biol. (2011)
Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus Sequence
Schwarz et al., J. Biol. Chem. (2011)
Chemokine Nitration Prevents Intratumoral Infiltration of Antigen-Specific T cells
Molon et al., J. Exp. Med. (2011)
Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation
Mendoza-Naranjo et al., J. Immunol. (2011)
The Immunodominant CD8 T Cell Response to the Human Cytomegalovirus Tegument Phosphoprotein pp65495–503 Epitope Critically Depends on CD4 T Cell Help in Vaccinated HLA-A*0201 Transgenic Mice
Reiser et al., J. Immunol. (2011)
Processing of HEBP1 by Cathepsin D Gives Rise to F2L, the Agonist of Formyl Peptide Receptor 3
Devosse et al., J. Immunol. (2011)
More references under JPT Publications/Literature
print